Fig. 2.

Change in mean HbA1c from index date to 6 months post-index for a the GLP-1 RA population and b the GLP-1 RA continuers subpopulation (patients who continued on their index GLP-1 RA therapy for ≥ 6 months). Data are mean ± standard deviation. Index date includes the closest available HbA1c assessment to the index date in a window of − 183 days to + 14 days; 6 months post-index includes the closest available HbA1c assessment to 183 days in a window of + 93 days to + 228 days. GLP-1 RA glucagon-like peptide-1 receptor agonist, HbA1c hemoglobin A1c